HOME >> MEDICINE >> NEWS
Study Finds Less Intensive Treatments May Not Maintain HIV Suppression

Triple-drug treatment regimens appear to be superior to less intensive "maintenance" therapies at maintaining HIV suppression, a study supported by the National Institute of Allergy and Infectious Diseases (NIAID) suggests. Among individuals participating in the study, known as AIDS Clinical Trials Group (ACTG) 343, those who switched from three-drug to two- or one-drug treatment regimens were more likely to experience a resurgence in their HIV levels. A report of the study appears in the Oct. 29, 1998 issue of the New England Journal of Medicine. Similar findings from a French research study are reported in the same issue.

"These findings suggest that patients who have responded well to intensive antiretroviral therapy, as evidenced by prolonged suppression of HIV viral load, should continue with their current treatment regimen," says NIAID Director Anthony S. Fauci, M.D. "Recent research describing persistent HIV reservoirs in individuals receiving highly active antiretroviral therapy (HAART) - even after their viral loads have been driven below the level of detection by current assays - points to the same conclusion." He adds, however, that these data do not eliminate the possibility that this may be a successful strategy for some patients.

Begun in early 1997, ACTG 343 is the first large-scale clinical trial to investigate whether one- or two-drug therapies can hold virus production at bay after HIV levels are driven down by intensive therapy. The multicenter study enrolled more than 500 individuals, each of whom had HIV viral loads greater than 1,000 copies of RNA per milliliter (ml) of blood and at least 200 CD4+ T cells per cubic millimeter (mm3) of blood. During the induction, or initial, phase of the study, all individuals received the protease inhibitor indinavir (IDV) in combination with zidovudine (AZT) and lamivudine (3TC).

After six months, more than 300 individuals whose viral loads had been reduced to 200 or fewer copies of HIV
'"/>

Contact: John Bowersox
jbowersox@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
28-Oct-1998


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/9/2018)... ... August 09, 2018 , ... ... monitoring with Smart-pill bottle and mobile applications, DoseSmart announced today the availability ... The DoseSmart medication management and medication adherence platform helps hospitals and health ...
(Date:8/7/2018)... (PRWEB) , ... August 07, 2018 , ... Sussex Vision ... with Blue Sky Vision. Michael Sussex, OD, founded the practice in Coldwater, and over ... practices with Matt Austin, OD, to offer comprehensive eye health services for patients of ...
(Date:8/3/2018)... , ... August 03, 2018 , ... On August 2, ... further proceedings. Mark Sadaka of Sadaka Associates, LLC has been litigating Zostavax ... argued before the Judicial Panel on Multidistrict Litigation for the thousands of people injured ...
(Date:8/2/2018)... ... August 02, 2018 , ... Allegheny Health Network ... connect clinicians inside and outside the network to vital patient imaging exams, saving ... AHN joins other leading hospital systems nationwide in using lifeIMAGE, which expands access ...
(Date:8/2/2018)... N.J. (PRWEB) , ... August 02, 2018 , ... ... 2018 will explore a range of topics in acute pain management. In The ... will discuss Michigan OPEN—the Opioid Prescribing Engagement Network—an innovative approach to the opioid ...
Breaking Medicine News(10 mins):
(Date:8/15/2018)... ... 2018 , ... Help Your Diabetes (HYD) is a Patent Pending, Internationally known, ... off their medication, working in conjunction with their primary physician. , The Founder/CEO, ... author of "Imagine Living Without Type 2 Diabetes. Dr. Hockings has given over 240 ...
(Date:8/15/2018)... ... August 15, 2018 , ... Schioppa Casters ... The newly designed Diamond Series features a caster specifically engineered for use ... antimicrobial compound injected into a thermoplastic resin during molding, Diamond Series casters provide ...
(Date:8/14/2018)... ANGELES (PRWEB) , ... August 14, 2018 , ... ... spearheading a unique fundraising event: The Saving Sophie Experience - A Journey To ... Hotel’s Tropicana Bar. Partygoers will have a meet and greet with Sophie herself, ...
Breaking Medicine Technology:
Cached News: